Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure

European Journal of Heart Failure

Volumn 9, Issue 3, 2007, Pages 287-291

  Nightingale, Angus K ^a,b   Crilley, Jenifer G ^c   Pegge, Nicholas C ^b   Boehm, Ernie A ^c,d   Mumford, Catherine ^b   Taylor, Doris J ^c,d   Styles, Peter ^c,d   Clarke, Kieran ^c   Frenneaux, Michael P ^b,e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Ascorbic acid; Chronic heart failure; Endothelial function; Magnetic resonance spectroscopy

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; PLACEBO; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; HEART FAILURE; HUMAN; HYPERAMMONEMIA; LONG TERM CARE; MALE; METABOLIC DISORDER; MUSCLE METABOLISM; OXYGEN TRANSPORT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; TREATMENT DURATION;

ADENOSINE TRIPHOSPHATE; AGED; ASCORBIC ACID; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; GREAT BRITAIN; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHOCREATINE;

EID: 33847276598     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.06.006     Document Type: Article

References (25)

1. Drexler H., Hayoz D., Munzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 69 19 (1992) 1596
2. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 16 (2000) 1899
3. Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98 24 (1998) 2709
4. Hambrecht R., Hilbrich L., Erbs S., et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral l-arginine supplementation. J Am Coll Cardiol 35 3 (2000) 706
5. Massie B.M., Conway M., Rajagopalan B., et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 78 2 (1988) 320
6. Wiener D.H., Fink L.I., Maris J., et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 73 6 (1986) 1127
7. Zelis R., Nellis S.H., Longhurst J., et al. Abnormalities in the regional circulations accompanying congestive heart failure. Prog Cardiovasc Dis 18 3 (1975) 181
8. Clark M.G., Rattigan S., Clerk L.H., et al. Nutritive and non-nutritive blood flow: rest and exercise. Acta Physiol Scand 168 4 (2000) 519
9. Reid M.B. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand 162 3 (1998) 401
10. Hornig B., Arakawa N., Kohler C., et al. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97 4 (1998) 363
11. Ellis G.R., Anderson R.A., Chirkov Y.Y., et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol 37 5 (2001) 564
12. Ellis G.R., Anderson R.A., Lang D., et al. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 36 5 (2000) 1474
13. Vuillemier J.P., and Keck E. Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J Micronutr Anal 5 (1989) 25
14. 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 6 5 (1993) 302
15. Naka K.K., Tweddel A.C., Doshi S.N., et al. Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J (2005)
16. Toussaint J.F., Koelling T.M., Schmidt C.J., et al. Local relation between oxidative metabolism and perfusion in leg muscles of patients with heart failure studied by magnetic resonance imaging and spectroscopy. J Heart Lung Transplant 17 9 (1998) 892
17. Maxwell A.J., Schauble E., Bernstein D., et al. Limb blood flow during exercise is dependent on nitric oxide. Circulation 98 4 (1998) 369
18. Adamopoulos S., Coats A.J., Brunotte F., et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 21 5 (1993) 1101
19. Hanada A., Okita K., Yonezawa K., et al. Dissociation between muscle metabolism and oxygen kinetics during recovery from exercise in patients with chronic heart failure. Heart 83 2 (2000) 161
20. Adams V., Yu J., Mobius-Winkler S., et al. Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure. Biochem Mol Med 61 2 (1997) 152
21. Reid M.B. Nitric oxide, reactive oxygen species, and skeletal muscle contraction. Med Sci Sports Exerc 33 3 (2001) 371
22. Wu F., Wislon J.X., and Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol 285 1 (2003) R50
23. Orzechowski A., Lokociejewska M., Muras P., and Hocquette J.F. Preconditioning with millimolar concentrations of vitamin C or N-acetylcysteine protects L6 muscle cells insulin-stimulated viability and DNA synthesis under oxidative stress. Life Sci 71 15 (2002) 1793
24. Sherman D.L., Keaney J.F., Biegelsen E.S., et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35 4 (2000) 936
25. Hornig B., Arakawa N., and Drexler H. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. Eur Heart J 19 (1998) G48 (Suppl G)